Sensitivity of QuantiFERON-TB GOLD In-Tube for diagnosis of recent versus remote M. tuberculosis infection

Diagnostic Microbiology and Infectious Disease

Volumn 73, Issue 3, 2012, Pages 257-259

  Bautista, Jemianne ^a   Banaei, Niaz ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

IGRA; Latent infection; M. tuberculosis; QuantiFERON; T SPOT.TB

Indexed keywords

GAMMA INTERFERON;

ADULT; ANALYTICAL EQUIPMENT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; TUBERCULIN TEST; TUBERCULOSIS; VALIDATION PROCESS;

ADULT; FEMALE; HUMANS; INTERFERON-GAMMA RELEASE TESTS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

EID: 84862163665     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.03.018     Document Type: Article

References (22)

1. Anonymous The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR Recomm Rep 1996, 45:1-18.
2. Adetifa I.M., Ota M.O., Walther B., Hammond A.S., Lugos M.D., Jeffries D.J., et al. Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis cases. PLoS One 2010, 5:e12502.
3. Andersen P., Munk M.E., Pollock J.M., Doherty T.M. Specific immune-based diagnosis of tuberculosis. Lancet 2000, 356:1099-1104.
4. Diel R., Goletti D., Ferrara G., Bothamley G., Cirillo D., Kampmann B., et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 2010, 37:88-99.
5. Diel R., Loddenkemper R., Meywald-Walter K., Niemann S., Nienhaus A. Predictive value of a whole blood IFN-γ assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 2008, 177:1164-1170.
6. Farhat M., Greenaway C., Pai M., Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?. Int J Tuberc Lung Dis 2006, 10:1192-1204.
7. Ferrara G., Losi M., D'Amico R., Cagarelli R., Pezzi A.M., Meacci M., et al. Interferon-gamma-release assays detect recent tuberculosis re-infection in elderly contacts. Int J Immunopathol Pharmacol 2009, 22:669-677.
8. Franken W.P., Arend S.M., Thijsen S.F., Bouwman J.J., Koster B.F., van Dissel J.T., et al. Interferon-gamma release assays during follow-up of tuberculin skin test-positive contacts. Int J Tuberc Lung Dis 2008, 12:1286-1294.
9. Grzybowski S., Styblo K., Dorken E. Tuberculosis in Eskimos. Tubercle 1976, 57:S1-58.
10. Herrera V., Perry S., Parsonnet J., Banaei N. Clinical application and limitations of IFN-γ release assays for the diagnosis of latent tuberculosis infection. Clin Infect Dis 2011, 52:1031-1037.
11. Hill P.C., Jackson-Sillah D.J., Fox A., Brookes R.H., de Jong B.C., Lugos M.D., et al. Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS One 2008, 3:e1379.
12. Horsburgh C.R., Rubin E.J. Clinical practice. Latent tuberculosis infection in the United States. N Engl J Med 2011, 364:1441-1448.
13. Kik S.V., Franken W.P., Mensen M., Cobelens F.G., Kamphorst M., Arend S.M., et al. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur Respir J 2010, 35:1346-1353.
14. Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest 2007, 131:1898-1906.
15. Landi S., Held H.R. Preparation and characterization of a large batch of tuberculin purified protein derivate (PPD-CT68). Ann Sclavo 1980, 22:899-907.
16. Menzies D., Pai M., Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007, 146:340-354.
17. Millington K.A., Innes J.A., Hackforth S., Hinks T.S., Deeks J.J., Dosanjh D.P., et al. Dynamic relationship between IFN-γ and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol 2007, 178:5217-5226.
18. Pai M. Alternatives to the tuberculin skin test: interferon-gamma assays in the diagnosis of mycobacterium tuberculosis infection. Indian J Med Microbiol 2005, 23:151-158.
19. Sester U., Fousse M., Dirks J., Mack U., Prasse A., Singh M., et al. Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states. PLoS One 2011, 6:e17813.
20. Sotgiu G. Diagnosis and treatment of latent tubercular infections. G Ital Med Lav Ergon 2010, 32:264-268.
21. Talati N.J., Seybold U., Humphrey B., Aina A., Tapia J., Weinfurter P., et al. Poor concordance between interferon-γ release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC Infect Dis 2009, 9:15.
22. van Zyl-Smit R.N., Pai M., Peprah K., Meldau R., Kieck J., Juritz J., et al. Within-subject variability and boosting of T-cell interferon-γ responses after tuberculin skin testing. Am J Respir Crit Care Med 2009, 180:49-58.